
Early-Onset Bilateral Cataracts Sequencing Panel
This program provides no-cost access to a 66-gene panel for U.S. patients aged 18 months to 35 years with current or historical idiopathic bilateral cataracts. The test evaluates key cataract, connexin, crystallin, developmental, and metabolic genes to support diagnosis and management, including early detection of CTX. Providers assess eligibility and oversee ordering, specimen collection, and result interpretation.